Rgenix Scores Rare Multimillion Dollar Funding Round for New York Biotech Scene

August 31, 2015 | The startup company has raised $8 million in new capital to develop drugs based on a discovery program that searches for targets by measuring microRNA expression in cancer. Xconomy